161 related articles for article (PubMed ID: 22499673)
1. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Loda E; Balabanov R
Rev Neurosci; 2012 Jan; 23(2):145-52. PubMed ID: 22499673
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
Ren Z; Wang Y; Tao D; Liebenson D; Liggett T; Goswami R; Clarke R; Stefoski D; Balabanov R
J Neurosci; 2011 Jun; 31(23):8329-41. PubMed ID: 21653838
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival.
Tegla CA; Cudrici C; Rus V; Ito T; Vlaicu S; Singh A; Rus H
J Neuroimmunol; 2009 Aug; 213(1-2):3-11. PubMed ID: 19577811
[TBL] [Abstract][Full Text] [Related]
4. Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune-mediated demyelinating diseases.
Stone S; Wu S; Jamison S; Durose W; Pallais JP; Lin W
Glia; 2018 Jul; 66(7):1331-1345. PubMed ID: 29436030
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis.
Balabanov R; Strand K; Goswami R; McMahon E; Begolka W; Miller SD; Popko B
J Neurosci; 2007 Feb; 27(8):2013-24. PubMed ID: 17314297
[TBL] [Abstract][Full Text] [Related]
6. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Patel J; Balabanov R
Int J Mol Sci; 2012; 13(8):10647-10659. PubMed ID: 22949885
[TBL] [Abstract][Full Text] [Related]
8. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
9. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
10. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
11. IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
Ren Z; Wang Y; Liebenson D; Liggett T; Goswami R; Stefoski D; Balabanov R
J Neuroimmunol; 2011 Apr; 233(1-2):147-59. PubMed ID: 21257209
[TBL] [Abstract][Full Text] [Related]
12. Oligodendrocyte-Specific Deletion of
Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405
[TBL] [Abstract][Full Text] [Related]
13. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
14. NF-κB Activation Accounts for the Cytoprotective Effects of PERK Activation on Oligodendrocytes during EAE.
Lei Z; Yue Y; Stone S; Wu S; Lin W
J Neurosci; 2020 Aug; 40(33):6444-6456. PubMed ID: 32661025
[TBL] [Abstract][Full Text] [Related]
15. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
Lin Y; Huang G; Jamison S; Li J; Harding HP; Ron D; Lin W
Am J Pathol; 2014 Feb; 184(2):507-19. PubMed ID: 24269558
[TBL] [Abstract][Full Text] [Related]
16. Genetic inactivation of PERK signaling in mouse oligodendrocytes: normal developmental myelination with increased susceptibility to inflammatory demyelination.
Hussien Y; Cavener DR; Popko B
Glia; 2014 May; 62(5):680-91. PubMed ID: 24481666
[TBL] [Abstract][Full Text] [Related]
17. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
18. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis.
Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T
Cells; 2019 Sep; 8(9):. PubMed ID: 31484369
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Lin W; Lin Y; Li J; Fenstermaker AG; Way SW; Clayton B; Jamison S; Harding HP; Ron D; Popko B
J Neurosci; 2013 Apr; 33(14):5980-91. PubMed ID: 23554479
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
